Technology & Software Global On demand · 24-48h

Global Prenatal Care Ultrasound AI Platform Market Strategic Research Report

Global Prenatal Care Ultrasound AI Platform Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Prenatal Care Ultrasound AI Platform Market
$2852025
17.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cloud-Based, On-Premise, Hybrid Cloud Architecture

By Application: Hospital, Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BrightHeart, Diagnoly, Sonio, Ultrasound AI, Caption Health, Philips, RayShape, Intelligent Ultrasound, Butterfly Network, UltraSight, Origin Medical, Mindray, GE HealthCare, Deepecho, BabyFlix, BioticsAI, Exo Imaging, Us2.ai, RIVANNA

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 139 pages
Market size 2025
$285
Million USD
Forecast CAGR
17.9%
2025-2032
Forecast 2032
$902.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Prenatal Care Ultrasound AI Platform market size is predicted to grow from US$ 285 million in 2025 to US$ 901 million in 2032; it is expected to grow at a CAGR of 17.9% from 2026 to 2032.

In 2025, the number of active paid accounts for the Prenatal Care Ultrasound AI Platform globally was approximately 16,200. Primarily charged on a "device-side licensing + cloud algorithm subscription" model, the average monthly subscription price was around $1,500 per device. The Prenatal Care Ultrasound AI Platform is an intelligent analysis system built upon deep learning algorithms and medical imaging big data training models. Embedded in the obstetric ultrasound workflow, it automatically identifies, segments, measures, and assesses the risk of abnormalities in fetal structural images, thus assisting physicians in completing systematic screening and structural assessments from early to late pregnancy. The platform typically covers automatic localization and standard section guidance of the fetal head (BPD, HC), abdomen (AC), femur length (FL), four-chamber view of the heart and outflow tract, spine, face, and major organ structures. It can also provide real-time alerts on whether images meet standards, whether there are structural defects, or an increased probability of abnormalities. Its core value is not to replace obstetricians, but rather to standardize measurement processes through algorithms, reduce human experience differences, and improve the early identification rate of abnormalities in complex structures (especially the fetal heart), thereby improving diagnostic consistency and screening efficiency. In terms of technical architecture, the platform typically employs convolutional neural networks (CNNs) or multimodal models to perform real-time inference on dynamic ultrasound images and interfaces with the DICOM system via cloud or local deployment to achieve case management and continuous model iteration. With the increase in computing power and data scale, prenatal ultrasound AI platforms are evolving from "automatic measurement tools" to "intelligent risk stratification and clinical decision support systems," becoming a key algorithmic infrastructure in the modern digital screening system for obstetrics.

Global key Prenatal Care Ultrasound AI Platform players cover BrightHeart, Diagnoly, Sonio, Ultrasound AI, Caption Health, etc.

This report presents a comprehensive overview of the global Prenatal Care Ultrasound AI Platform market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Deployment Method

  • Cloud-Based
  • On-Premise
  • Hybrid Cloud Architecture

Segment by Functional Hierarchy

  • Image Enhancement
  • Automatic Structure Recognition
  • Automatic Measurement
  • Anomaly Risk Scoring
  • Others

Segment by Business Model

  • Single Device Licensing
  • SaaS Platform Subscription
  • Healthcare Group-Level Subscription
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Prenatal Care Ultrasound AI Platform market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Prenatal Care Ultrasound AI Platform Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 17.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$285
2025
Forecast
$902.5
2032
CAGR
17.9%
2025–2032
Regions
5
global
Key companies
BrightHeartDiagnolySonioUltrasound AICaption HealthPhilipsRayShapeIntelligent Ultrasound
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Cloud-BasedOn-PremiseHybrid Cloud Architecture
By Application
HospitalClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cloud-Based
  • 3.1.3 On-Premise
  • 3.1.4 Hybrid Cloud Architecture
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BrightHeart
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Diagnoly
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sonio
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ultrasound AI
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Caption Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Philips
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 RayShape
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Intelligent Ultrasound
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Butterfly Network
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 UltraSight
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Origin Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Mindray
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 GE HealthCare
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Deepecho
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 BabyFlix
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BioticsAI
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Exo Imaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Us2.ai
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 RIVANNA
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Prenatal Care Ultrasound AI Platform market?
The global Prenatal Care Ultrasound AI Platform market is estimated at US$ 285 million in 2025 (base year) and is projected to reach US$ 901 million by 2032.
What is the forecast CAGR for the Prenatal Care Ultrasound AI Platform market?
The market is expected to grow at a CAGR of 17.9% from 2026 to 2032, expanding from US$ 285 million in 2025 to US$ 901 million in 2032, roughly 3.2 times its base-year value.
What is Prenatal Care Ultrasound AI Platform?
In 2025, the number of active paid accounts for the Prenatal Care Ultrasound AI Platform globally was approximately 16,200. Primarily charged on a "device-side licensing + cloud algorithm subscription" model, the average monthly subscription price was around $1,500 per device. The Prenatal Care Ultrasound AI Platform is an intelligent analysis system built upon deep learning algorithms and medical imaging big data training models.
What are the main segments of the Prenatal Care Ultrasound AI Platform market by deployment method?
By deployment method, the market is segmented into Cloud-Based, On-Premise and Hybrid Cloud Architecture.
Which applications drive demand in the Prenatal Care Ultrasound AI Platform market?
Key applications covered include Hospital, Clinic and Others.
Who are the key players in the Prenatal Care Ultrasound AI Platform market?
Key players profiled include BrightHeart, Diagnoly, Sonio, Ultrasound AI, Caption Health, Philips, RayShape and Intelligent Ultrasound, among 19 companies covered in total.
Which regions and countries are covered for Prenatal Care Ultrasound AI Platform?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Prenatal Care Ultrasound AI Platform market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Prenatal Care Ultrasound AI Platform market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.